Received May 21, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | U8670BA | — |
| TDAP | TDAP (ADACEL) | SANOFI PASTEUR | UNK | — | — |
a 10-year-old patient administered with VAXELIS and TDaP (ADACEL) at the same time.; a 10-year-old patient administered with VAXELIS and TDaP (ADACEL) at the same time; a 10-year-old patient administered with VAXELIS and TDaP (ADACEL) at the same time; redness; swelling; itchiness; tenderness; This non-serious spontaneous Safety Report was received with reference number: IN-260407-96199 (Interation number: 02861124) by Partner on 06-APR-2026 and forwarded on 07-APR-2026 from a health professional. Due to the nature of the event the causal relationship between the events of a 10-year-old patient administered with VAXELIS and TDaP (ADACEL) at the same time, Product use issue, and Overdose' and Vaxelis is not applicable. This case is considered off-label use. Further information expected. SIGNIFICANT FOLLOW-UP INFORMATION received with reference number: IN-260407-96199 (Interation number: 02861124) through fax on 27-APR-2026 from a health professional. Due to the nature of the event the causal relationship between the events of a 10-year-old patient administered with VAXELIS and TDaP (ADACEL) at the same time, Product use issue, and Overdose' and Vaxelis is not applicable. This case is considered off-label use. No Further information expected.
Prophylaxis